GALECTIN THERAPEUTICS INC Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Galectin Therapeutics Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Galectin Therapeutics Inc Debt-to-equity for the quarter ending June 30, 2024 was -136 %, a 7.51% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -136 +11 +7.51% Jun 30, 2024
Q1 2024 -137 +28.5 +17.2% Mar 31, 2024
Q4 2023 -140 +71.3 +33.8% Dec 31, 2023
Q3 2023 -142 +192 +57.5% Sep 30, 2023
Q2 2023 -147 +759 +83.8% Jun 30, 2023
Q1 2023 -166 -946 -121% Mar 31, 2023
Q4 2022 -211 -431 -196% Dec 31, 2022
Q3 2022 -334 -423 -475% Sep 30, 2022
Q2 2022 -906 -940 -2742% Jun 30, 2022
Q1 2022 781 +764 +4713% Mar 31, 2022
Q4 2021 221 +210 +1989% Dec 31, 2021
Q3 2021 89.1 +81.7 +1110% Sep 30, 2021
Q2 2021 34.3 +28.4 +487% Jun 30, 2021
Q1 2021 16.2 +12.4 +329% Mar 31, 2021
Q4 2020 10.6 +6.11 +137% Dec 31, 2020
Q3 2020 7.36 +2.02 +37.8% Sep 30, 2020
Q2 2020 5.84 -3.25 -35.7% Jun 30, 2020
Q1 2020 3.78 -20.4 -84.4% Mar 31, 2020
Q4 2019 4.45 -30.5 -87.3% Dec 31, 2019
Q3 2019 5.34 -47.8 -89.9% Sep 30, 2019
Q2 2019 9.09 -108 -92.3% Jun 30, 2019
Q1 2019 24.1 -217 -90% Mar 31, 2019
Q4 2018 34.9 -87.3 -71.4% Dec 31, 2018
Q3 2018 53.1 -15.7 -22.8% Sep 30, 2018
Q2 2018 117 +69.1 +143% Jun 30, 2018
Q1 2018 241 +197 +447% Mar 31, 2018
Q4 2017 122 +85.8 +236% Dec 31, 2017
Q3 2017 68.8 +43.3 +170% Sep 30, 2017
Q2 2017 48.3 +28.7 +146% Jun 30, 2017
Q1 2017 44.1 +30.6 +227% Mar 31, 2017
Q4 2016 36.4 +27.5 +309% Dec 31, 2016
Q3 2016 25.5 +16.6 +184% Sep 30, 2016
Q2 2016 19.6 +12.2 +163% Jun 30, 2016
Q1 2016 13.5 +6.38 +90% Mar 31, 2016
Q4 2015 8.9 +1.62 +22.2% Dec 31, 2015
Q3 2015 8.99 -1.12 -11.1% Sep 30, 2015
Q2 2015 7.47 -6.93 -48.1% Jun 30, 2015
Q1 2015 7.09 -19.8 -73.7% Mar 31, 2015
Q4 2014 7.28 +533 Dec 31, 2014
Q3 2014 10.1 +385 Sep 30, 2014
Q2 2014 14.4 -6.23K -99.8% Jun 30, 2014
Q1 2014 26.9 -51.4 -65.6% Mar 31, 2014
Q4 2013 -525 -569 -1297% Dec 31, 2013
Q3 2013 -375 -434 -726% Sep 30, 2013
Q2 2013 6.24K +6.18K +9276% Jun 30, 2013
Q1 2013 78.3 -14.2 -15.3% Mar 31, 2013
Q4 2012 43.9 Dec 31, 2012
Q3 2012 59.8 Sep 30, 2012
Q2 2012 66.6 Jun 30, 2012
Q1 2012 92.5 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.